Search Medical Condition
Please enter condition
Please choose location

Liver Disease Clinical Trials

A listing of Liver Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (450) clinical trials

Do you have impaired liver function? Wake Research Associates is enrolling volunteers with liver disease in a clinical research study testing an investigational medication for impaired liver function.

Phase N/A

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. ClinSearch is enrolling volunteers in a study of an investigational medication for people with decompensated cirrhosis from NASH.

Phase N/A

Nonalcoholic fatty liver disease (NAFLD) is liver inflammation caused by a buildup of fat in the liver. Wake Research Associates is enrolling volunteers with NAFLD in a study testing an investigational medication.

Phase N/A

Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for patients with non-alcoholic fatty liver disease accompanied by high cholesterol. Non-alcoholic Fatty Liver disease doesn’t usually have symptoms, but you may be at risk if you are overweight and fatigued. Qualified participants receive study-related medical ...

Phase N/A

A research study is evaluating an investigational medication for NASH (Nonalcoholic steatohepatitis), a type of Nonalcoholic Fatty Liver Disease. This research study may be an option if you: Have liver biopsy results showing evidence of NASH Do not have any other liver conditions (such as but not limited to: hepatitis ...

Phase N/A

A randomized, double-blind, placebo-controlled phase III study of regorafenib plus best supportive care versus placebo plus best supportive care for subjects with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite prior treatment with at least imatinib and sunitinib. The study is composed of 3 periods: A ...

Phase

The AURORA study will be conducted in 2 parts. Part 1 will examine the surrogate endpoint of improvement in fibrosis of at least 1 stage (nonalcoholic steatohepatitis clinical research network [NASH CRN]) and no worsening of steatohepatitis at Month 12. Subjects from Part 1 will continue into Part 2 and ...

Phase

This study is being conducted to evaluate the efficacy, safety and tolerability of GSK2330672 administration for the treatment of pruritus (itch) in participants with primary biliary cholangitis (PBC). Participants will be treated with either placebo or one of the 4 dose regimens of GSK2330672 (20 milligram [mg], 90 mg or ...

Phase

This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may ...

Phase N/A

Experiencing nonalcoholic fatty liver disease (NAFLD)? ClinSearch is enrolling individuals with this condition in a clinical research study. Study duration for qualified volunteers is 11-14 weeks. Eligibility Criteria: To qualify, you must: -Be 18-65 years old -Have nonalcoholic fatty liver disease -Have Type 2 Diabetes Other Details: Qualified participants may ...

Phase N/A